Mechanisms of atrial fibrillation: rotors, ionic determinants, and excitation frequencyRight ventricular dysfunction in chronic lung diseaseSurgery for atrial fibrillationAnatomy of the mitral valve apparatus: role of 2D and 3D echocardiographyRisk Factors and Genetics of Atrial FibrillationAnticoagulation for atrial fibrillationControversies in heart failure. Are beneficial effects of angiotensin-converting enzyme inhibitors attenuated by aspirin in patients with heart failure?To anticoagulate or not to anticoagulate patients with cardiomyopathyAcute ischemic syndromes. Early responsePathogenesis and early management of non-ST-segment elevation acute coronary syndromesEvaluation and management of the patient who has cocaine-associated chest painEnvironmental Exposures and Cardiovascular Disease: A Challenge for Health and Development in Low- and Middle-Income CountriesGlobal Shifts in Cardiovascular Disease, the Epidemiologic Transition, and Other Contributing Factors: Toward a New Practice of Global Health CardiologyThe Effects of Dietary Factors on Blood Pressure.Innovative Approaches to Hypertension Control in Low- and Middle-Income Countries.Diagnosis and Management of Endomyocardial Fibrosis.Cardiac Disease Associated with Human Immunodeficiency Virus Infection.Electrophysiology in the Developing World: Challenges and Opportunities.Chagas Cardiomyopathy: Clinical Presentation and Management in the Americas.Rheumatic Heart Disease: The Unfinished Global Agenda.Infective Endocarditis in Low- and Middle-Income Countries.Approaches to Sustainable Capacity Building for Cardiovascular Disease Care in Kenya.Tuberculosis and the Heart.mHealth Interventions to Counter Noncommunicable Diseases in Developing Countries: Still an Uncertain Promise.Ensuring Patient-Centered Access to Cardiovascular Disease Medicines in Low-Income and Middle-Income Countries Through Health-System Strengthening.Ambulatory Blood Pressure Monitoring: A Complementary Strategy for Hypertension Diagnosis and Management in Low-Income and Middle-Income Countries.Using the 12-Lead Electrocardiogram in the Care of Athletic Patients.Sudden Cardiac Death in Athletes: Still Much to Learn.Special Situations in Pulmonary Hypertension: Pregnancy and Right Ventricular Failure.Pulmonary Hypertension in Children.Group 5 Pulmonary Hypertension: The Orphan's Orphan Disease.Group 4 Pulmonary Hypertension: Chronic Thromboembolic Pulmonary Hypertension: Epidemiology, Pathophysiology, and Treatment.Group III Pulmonary Hypertension: Pulmonary Hypertension Associated with Lung Disease: Epidemiology, Pathophysiology, and Treatments.Group 2 Pulmonary Hypertension: Pulmonary Venous Hypertension: Epidemiology and Pathophysiology.Pulmonary Hypertension and Congenital Heart Disease.World Health Organization Group I Pulmonary Hypertension: Epidemiology and Pathophysiology.Congenital Heart Disease and the Athlete: What We Know and What We Do Not Know.The role of transesophageal echocardiography in atrial fibrillation.Antiarrhythmic drug therapy of atrial fibrillation.Role of catheter and surgical ablation in congenital heart disease.
P1433
Q26865072-319FC5AD-EFB2-4FBE-BA66-6BB5ACDF619BQ27002670-8B7E51C2-E7CE-410B-A62F-8060C145FABAQ27022070-04729F99-EF62-43B3-BCC7-31BB940E2DCDQ27023090-EA242873-5D83-4C91-BE56-6E8CE8140506Q28111688-9E55431A-1611-4CB0-966F-D21FD747B063Q28167527-AF8149AD-B148-4FB4-B17D-05D82B02C5B2Q28191697-5E2B0FE2-88BB-44BD-9379-B4FF6A2222D6Q28191701-AC0039C1-194A-4F8F-8028-CABB0C0C6CF5Q28192369-C2762BA9-2E68-473F-B252-BDCA824E970EQ28193737-818FF8F5-4BFE-4802-8ECD-7FF77363FE0EQ28193741-84DD754E-1B40-4421-A270-3748679A32B5Q28395373-B4474885-C9E9-48A3-8340-C18618C30CFFQ28395689-E0418833-0F37-458E-B51B-433525126697Q30234789-554024F0-9804-4223-9BAA-340431902EE6Q30240646-A9D3CB10-DC97-44A5-B352-E4855295FF8BQ30240648-1DA4C1BB-5A97-4748-B893-389BF5FF066CQ30240651-29140FB7-92E4-44E7-987D-7FC39D6A0781Q30240653-4345E6CE-7BAB-4968-8593-24053CD08B22Q30240658-CC147470-A143-46D7-9948-85E580533351Q30240660-F0E4A74D-42EF-494D-BFFE-944260D465E8Q30240663-559884C9-E2B4-4FD2-AE5F-D5A9350C6B64Q30240665-1B62F3EB-A23B-45F5-818B-A0D2B6428E56Q30240667-2CFCC9FD-8E43-4072-BEDB-FBACE4C34BA0Q30240669-D4C52C0A-42A4-445E-8638-3512AF0B5EFEQ30240671-1CC415A0-0116-4906-AE70-3CD259D19411Q30240673-677FD4C7-9B86-4892-83E7-93AB94FFE89BQ30244962-E7C22CDB-9C6E-4D63-BE38-FE604DAD0D48Q30244964-2D48E575-8152-47A2-AA66-61CCB7C4E42BQ30248870-26D3C974-3690-403D-A9AC-591834B16022Q30248871-F38A6C8C-CC90-44E7-A73F-BCE1DE82FC4EQ30248872-7C99AE7A-F8DF-42FB-B625-596655B80BC4Q30248874-CB398C2F-E3B0-4C95-8E07-45EDED188934Q30248875-3941D639-3352-4649-BADF-2DC2B3993589Q30248876-D903A8F5-DFA0-4422-8075-C1381E2C7C11Q30248877-4E890041-8569-4C1D-8D32-A41C602F7C42Q30248878-5A3DD5B1-B0B5-4EA2-AABF-D13FDAE9201FQ30275806-7B7C5683-0A86-4304-AB0F-25A04A06C198Q30312178-4827186E-AE84-4D00-B369-5C813E858612Q30312187-EF6F0F48-733F-4927-AF30-76EFC0CA8A7AQ30332035-63F441B4-25DC-4DEB-B8F4-3AF27AB4C259
P1433
description
periodiek van uitgeverij Elsevier
@nl
name
Cardiology Clinics
@nl
type
label
Cardiology Clinics
@nl
prefLabel
Cardiology Clinics
@nl
P3181
P1055
P1156
P123
P1250
P1277
P1476
Cardiology Clinics
@und